STOCK TITAN

Atea Pharmaceuticals director proposes 8,750-share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Atea Pharmaceuticals, Inc. (AVIR) director Bruce Polsky reported a proposed sale of 8,750 common shares, with an aggregate market value of $35,299.25 and an approximate sale date of November 19, 2026. The shares were acquired from the issuer on November 16, 2026, in an exercised-shares transaction paid for in cash. The notice also lists three sales during the past three months: 14,254 shares for gross proceeds of $60,840.35 on November 16; 8,720 shares for $35,155.55 on November 17; and 18,252 shares for $72,099.05 on November 18, 2026.

Proposed sale 8,750 shares Approximate sale date November 19, 2026
Aggregate market value $35,299.25 Proposed sale
Shares sold 14,254 shares November 16, 2026
Gross proceeds $60,840.35 Sale on November 16, 2026
Shares sold 8,720 shares November 17, 2026
Gross proceeds $35,155.55 Sale on November 17, 2026
Shares sold 18,252 shares November 18, 2026
Gross proceeds $72,099.05 Sale on November 18, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Atea Pharmaceuticals (AVIR) director Bruce Polsky propose to sell?

The notice lists a proposed sale of 8,750 common shares, with an aggregate market value of $35,299.25 and an approximate sale date of November 19, 2026.

What shares did Atea Pharmaceuticals (AVIR) director Bruce Polsky sell in the prior three months?

The notice lists three sales: 14,254 shares for gross proceeds of $60,840.35 on November 16, 8,720 shares for $35,155.55 on November 17, and 18,252 shares for $72,099.05 on November 18, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading